EMILY BROWN DIDRICK: Open Payments
NPI 1740701366 · ATLANTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,109 in 89 payments from 15 companies in 2025. Trend: 2023 $1,364 · 2024 $1,604 · 2025 $2,109
Food & beverage: $2,109
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 26 | $505 |
| ABBVIE INC. | 11 | $257 |
| Organon LLC | 7 | $250 |
| Regeneron Healthcare Solutions, Inc. | 8 | $203 |
| GENZYME CORPORATION | 6 | $174 |
| Botanix SB Inc | 7 | $140 |
| UCB, Inc. | 4 | $107 |
| Galderma Laboratories, L.P. | 5 | $100 |
| Novartis Pharmaceuticals Corporation | 3 | $88 |
| LEO Pharma Inc. | 3 | $78 |
Products named: CIBINQO, DUPIXENT, VTAMA, RINVOQ, SOFDRA, Bimzelx, LITFULO, NEMLUVIO.
Industry payments across GA — which companies pay providers there.
